Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of standardized therapy for older adults with newly diagnosed acute lymphoblastic leukemia
NL-OMON41230Phase 2Active, not recruiting
- Sponsor
- Cancer Research UK
- Start
- Jan 2016
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in acute lymphoblastic leukemia (ALL), sponsored by Cancer Research UK. Primary endpoint: Complete remission rate after 2 phases of induction. Started Jan 2016; status: active, not recruiting.
02
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NL-OMON41230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41230.